Product Information：
- Product name: Ruxolitinib 20mg
- Manufacturer / brand: Laos Alliance
- Active ingredient: Ruxolitinib
- Current strength:20mg
- SKU: 04-L-1328
- Site category: myelofibrosis, other cancer
Active Ingredient and Reference Data
Ruxolitinib is the active ingredient used for this product page. Public prescribing information for Ruxolitinib was used for the medical reference sections. Medical details are provided for reference and must be interpreted by a qualified healthcare professional.
Mechanism of Action
Ruxolitinib (Jakafi) is an oral JAK1/JAK2 inhibitor that blocks the JAK-STAT signaling pathway, suppressing abnormal hematopoietic cell proliferation and proinflammatory cytokine release to reduce splenomegaly and improve symptoms of myelofibrosis, PV, and GVHD.
Storage and Purchase Notes
Store according to the package or pharmacist instructions and keep out of reach of children. Before ordering, confirm product name, strength, quantity, price, shipping details, and payment method. After receipt, check packaging, batch number, expiration date, and storage conditions.
Reviews
There are no reviews yet.